The
generally cleared indication for the ResQPOD is a temporary increase
in blood circulation during emergency care, hospital, clinic and
home use.
Research is ongoing in the United States to evaluate the long-term
benefit of the ResQPOD for indications related to patients suffering
from cardiac arrest.
For more information on completed
clinical studies click here. The references on this website are not
intended to imply specific outcome-based claims not yet cleared by the
US Food and Drug Administration.
|
|
|
